Skip to content

Feasibility Study: Evaluation of the Ulthera® System for Treatment of the Décolleté

Feasibility Study: Evaluation of the Ulthera® System for Lifting and Tightening of the Décolleté

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01485107
Enrollment
24
Registered
2011-12-05
Start date
2011-06-30
Completion date
2012-05-31
Last updated
2017-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Laxity of the décolleté

Keywords

Ulthera® System, Ultherapy™ treatment, Ulthera, Inc., Ultrasound treatment for skin tightening

Brief summary

Up to 20 subjects will be enrolled. Subjects will receive treatment of the décolleté using the Ulthera® System. Subjects will be return for follow-up visits at 90 and 180 days post-treatment. The study will evaluate the effectiveness of the Ulthera® System to lift and tighten the skin of the décolleté region.

Detailed description

This is a prospective, single-center study. Baseline Fabi/Bolton 5-Point Chest Wrinkle scale scores and chest measurements will be assessed prior to study treatment. Study images will be obtained pre-treatment, immediate post-treatment, and at each follow-up visit.

Interventions

Focused ultrasound energy delivered below the surface of the skin.

Sponsors

Ulthera, Inc
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Female, aged 35 to 60 years. * Subject in good health. * Moderate to severe (grade of ≥3 on Fabi/Bolton scale) skin laxity on the décolleté. * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period. * Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study.

Exclusion criteria

* Presence of an active systemic or local skin disease that may affect wound healing. * Scarring in areas to be treated. * Tattoos in the areas to be treated. * Patients with ports or defibrillators. * Breast size \>400cc each as measured by water displacement method. * History of breast reduction surgery. * Any open wounds or lesions in the area. * Active and severe inflammatory acne in the region to be treated. * Patients who have a history with keloid formation or hypertropic scarring

Design outcomes

Primary

MeasureTime frameDescription
Improvement in overall lifting and tightening of skin90 days post-treatmentLifting and tightening of décolleté skin as determined by a masked, qualitative assessment of photographs at 90 days posttreatment compared to baseline.

Secondary

MeasureTime frameDescription
Bilateral chest measurements90 and 180 days post-treatmentMeasurements from mid-clavicle to nipple obtained at each follow-up visit compared to baseline to assess for lifting and tightening of skin.
Skin Laxity of the Décolleté90 and 180 days post-treatmentThe amount of skin laxity will be assessed using the Fabi/Bolton 5-Point Chest Wrinkle Scale. Skin laxity will be assessed at each follow-up visit compared to baseline.
Overall aesthetic improvement90 and 180 days post-treatmentBased on Global Aesthetic Improvement Scale (GAIS) scores.
Patient satisfaction90 and 180 days post-treatmentSubject-completed questionnaire.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026